Clinical Trial Update: Efficacy Trial of a Commercial EV71 Vaccine [Phase 4]

View source ↗

Summary

Phase 4 efficacy trial of a commercial EV71 vaccine for Hand, Foot and Mouth Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (enterovirus 71 vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: COMPLETED